EP Patent

EP1201240A3 — Heterocyclic derivatives useful as pharmaceutical agents

Assigned to Warner Lambert Co LLC · Expires 2003-04-09 · 23y expired

What this patent protects

This invention relates to novel heterocyclic derivatives of the formula (VII), (VIII) or (IX) in which P, Q , R 1 - R 6 , m and n are as defined in the specification, and to pharmaceutically acceptable salts thereof. The compounds and pharmaceutical compositions containing the…

USPTO Abstract

This invention relates to novel heterocyclic derivatives of the formula (VII), (VIII) or (IX) in which P, Q , R 1 - R 6 , m and n are as defined in the specification, and to pharmaceutically acceptable salts thereof. The compounds and pharmaceutical compositions containing them are useful in the treatment of a range of disorders including epilepsy, faintness attacks, hypokinesia, cranial disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases and gastrointestinal disorders, especially irritable bowel syndrome.

Drugs covered by this patent

Patent Metadata

Patent number
EP1201240A3
Jurisdiction
EP
Classification
—
Expires
2003-04-09
Drug substance claim
No
Drug product claim
No
Assignee
Warner Lambert Co LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.